The highs and lows of intensive insulin therapy

[1] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341

[2] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871

[3] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709

[4] Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1301 - 1308

[5] Intensive insulin therapy in postoperative intensive care unit patients - A decision analysis [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (04) : 407 - 413

[6] FIETSAM R, 1991, AM SURGEON, V57, P551

[7] Glucose control and mortality in critically ill patients [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 2041 - 2047

[8] Early goal-directed therapy in the treatment of severe sepsis and septic shock. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1368 - 1377

[9] THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) : 977 - 986

[10] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. LANCET, 1998, 352 (9131) : 837 - 853

[1] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341

[2] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871

[3] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709

[4] Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1301 - 1308

[5] Intensive insulin therapy in postoperative intensive care unit patients - A decision analysis [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (04) : 407 - 413

[6] FIETSAM R, 1991, AM SURGEON, V57, P551

[7] Glucose control and mortality in critically ill patients [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 2041 - 2047

[8] Early goal-directed therapy in the treatment of severe sepsis and septic shock. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1368 - 1377

[9] THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) : 977 - 986

[10] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. LANCET, 1998, 352 (9131) : 837 - 853